Table 5.
The results of univariate and multivariate (sequential) logistic regression analyses to predict health benefits experienced by peri- and postmenopausal women using menopausal hormone therapy
| Menopausal status | Area of health benefits | Univariate model | Multivariate model | |||
|---|---|---|---|---|---|---|
| Observed n (%) | Not observed n (%) | OR (95% CI) | p | aOR (95% CI) | p | |
| Relieve menopausal symptoms | ||||||
| Perimenopausal Postmenopausal |
45 (91.8) 86 (78.9) |
4 (8.2) 23 (21.1) |
3.01 (0.97–9.32) |
0.046 | 1.86 (0.56; 6.13) |
0.307 |
| Emotional condition | ||||||
| Perimenopausal Postmenopausal |
23 (46.9) 42 (38.5) |
26 (53.1) 67 (61.5) |
1.41 (0.71–2.80) |
0.323 | – | – |
| Sexual life | ||||||
| Perimenopausal Postmenopausal |
31 (63.3) 26 (23.8) |
18 (36.7) 83 (76.2) |
5.55 (2.64–11.46) |
< 0.001 | 5.01 (2.37–0.61) |
< 0.001 |
| Physical activity | ||||||
| Perimenopausal Postmenopausal |
6 (12.2) 11 (10.1) |
43 (87.8) 98 (89.9) |
1.27 (0.43–3.61) |
0.687 | – | – |
| State of heart & blood vessels | ||||||
| Perimenopausal Postmenopausal |
8 (16.3) 19 (17.4) |
41 (83.7) 90 (82.6) |
0.95 (0.37–2.30) |
0.865 | – | – |
| Skin condition | ||||||
| Perimenopausal Postmenopausal |
9 (18.4) 12 (11.0) |
40 (81.6) 97 (89.0) |
1.88 (0.71–4.69) |
0.214 | – | – |
| Bones and joints condition | ||||||
| Perimenopausal Postmenopausal |
4 (8.2) 8 (7.3) |
45 (91.8) 101 (92.7) |
1.12 (0.21–3.28) |
0.782 | – | – |
MHT – menopausal hormone therapy, OR – odds ratio, aOR – adjusted odds ratio, CI – confidence interval